Cockayne syndrome
Log in to starLast updated Nov 3, 2026
A child who was normal at birth develops progressive growth failure, photosensitivity, and neurological regression. He has a characteristic cachectic appearance with sunken eyes.
AR; ERCC6 (DNA excision repair protein ERCC-6, also called CSB; about 65%) or ERCC8 (DNA excision repair protein ERCC-8, also called CSA; about 35%); loss of function
- Defective transcription-coupled nucleotide excision repair (one of several DNA repair mechanisms)
ERCC-6 and ERCC-8 both work in transcription-coupled nucleotide excision repair, the branch of DNA repair that removes UV-induced pyrimidine dimers and other lesions blocking transcription on the transcribed strand of active genes. ERCC-6 has helicase-like domains and appears to help RNA polymerase II elongate transcripts; ERCC-8 is part of a cullin 4 E3 ubiquitin ligase complex. Pathogenic variants cause loss of function.
Loss of this repair explains the photosensitivity, but not the growth failure and neurodegeneration. The contrast with xeroderma pigmentosum shows why: most people with XP lack both transcription-coupled and global genome repair, yet grow and develop normally. Other roles proposed for the CS proteins, in restarting transcription after genotoxic stress, repairing oxidative DNA damage, and mitochondrial metabolism, may account for the rest.
People with Cockayne syndrome are not predisposed to skin cancer, possibly because cells are deficient in both transcription and proliferation. Growth hormone could in theory reverse that protection, which is why it is not recommended. In one study, people with ERCC8 variants were less severely affected at diagnosis than those with ERCC6 variants.
- Postnatal growth failure (cachectic habitus)
- Photosensitivity (but NO increased skin cancer risk)
- Progressive neurological deterioration
- Sensorineural hearing loss
- Pigmentary retinopathy
- Dental caries
- Characteristic facies: sunken eyes, prominent ears
Overlap: Related to xeroderma pigmentosum (same nucleotide excision repair pathway: Cockayne syndrome lacks the transcription-coupled branch, while most XP lacks both branches)
- Clinical recognition: postnatal growth failure, cutaneous photosensitivity, progressive neurologic decline, and cachectic facies
- Confirm with molecular testing of ERCC6 (CSB) and ERCC8 (CSA), typically via a multigene panel
- Supportive findings: cerebellar/cerebral atrophy with intracranial calcifications on MRI/CT, demyelinating peripheral neuropathy, and a DNA-repair (RNA synthesis recovery) cellular assay in selected cases
- Supportive, multidisciplinary care: nutrition and feeding support, physical/occupational therapy for contractures, and developmental support
- Strict photoprotection (sun avoidance, sunscreen); periodic ophthalmology (cataract, retinopathy) and audiology surveillance
- Monitor for and treat hypertension, renal dysfunction, dental caries, and tremor/spasticity; avoid metronidazole (reports of acute hepatic decompensation)
"CockayNE has defective NER": Cockayne syndrome is caused by defective nucleotide excision repair (NER), specifically transcription-coupled repair, in ERCC6 or ERCC8.
"C0CKAYNE": microCephaly (progressive), 0% centile for growth & 0% cancer risk, Kyphosis, Aging (premature), mYelination defect, Nucleotide Excision repair (ERCC6/8)
"Cockayne is Compact": Short stature and FTT.
ERCC in Cockayne: The letters ERCC are hidden inside "CockaynE syndRome, transCription-Coupled repair."